Skip to content

Serratus Posterior Plane Block vs Erector Spine Plane Block

Continuous Serratus Posterior Plane Block Versus Continuous Erector Spine Plane Block for Video-assisted Thoracoscopic Surgery: a Prospective Randomized Non-inferiority Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07021131
Enrollment
100
Registered
2025-06-13
Start date
2025-07-01
Completion date
2026-07-01
Last updated
2025-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Regional Anesthesia

Brief summary

Analgesia related to the administration of local anesthetic solution into the fascia of erector spinae muscle is mediated by the effect of local anesthetic on the posterior and lateral branches of the anterior part of the spinal nerve. Comparable analgesic efficiency after the administration of both nerve blocks would reject the widespread theory of the paravertebral site of effect of the local anesthetic in ESPB.

Interventions

PROCEDUREnew type of peripheral block Serratus Posterior Plane Block

Intervention will be Serratus Posterior Plane Block.

Sponsors

Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patiens undergoing VATS-surgery

Exclusion criteria

* Age \< 20 years * Body Mass Index \>35 kg/m2 * Technical difficulties with the nerve block administration and/or subsequent bolus application * Abnormal course of the surgery (e.g. conversion to thoracotomy) or the postoperative phase (e.g. surgical revision of the chest) * Patient's refusal

Design outcomes

Primary

MeasureTime frameDescription
Cumulative opioid dose in 72 hoursfrom end of surgery to 72 hours after the end surgeryIrrespective of the type of the block, 20 mls of 0.25 % bupivacaine will be administered to the block catether every 8 hours. Every patients will receive non-opioid analgesics according to standardized ward guideline. VAS score is recorded at least every 3 hours (except for time patient is asleep). Any time patient reports VAS score \>=5, he/she will receive 5 mg of morphine intravenously (or equivalent dose of Oxycodone per os). Cumulative dose of opioids will be recorded.

Countries

Czechia

Contacts

Primary ContactDaniel Nalos
nalosdan@seznam.cz+420737230792
Backup ContactOndrej Maly
ondrej.maly@kzcr.eu+420774145512

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026